Research and Development
Horizon to acquire worldwide rights to Boehringer Ingelheim genetic disease drug
May 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, actimmune, agreement, horizon, interferon gamma-1b, worldwide rights
UK regulators do not back Roche’s breast cancer drug
May 20, 2016 Medical Communications, Research and Development, Sales and Marketing NICE, Perjeta, Roche, breast cancer, recommendation
Chugai partners with Osaka University in £62 million immunology collaboration
May 20, 2016 Medical Communications, Research and Development Chugai, collaboration, immunology, osaka university
Celator receives FDA breakthrough therapy designation for leukaemia drug
May 20, 2016 Medical Communications, Research and Development FDA, Vyxeos, acute myeloid leukaemia, breakthrough therapy, celator
Urgent action needed on antimicrobial resistance, says government report
May 19, 2016 Manufacturing and Production, Medical Communications, Research and Development ABPI, Lord Jim O'Neill, NICE, antimicrobial resistance
Darzalex meets endpoint in late-stage multiple myeloma trial
May 19, 2016 Research and Development Genmab, Janssen, daratumumab, darzalex, dexamethasone, lenalidomide, phase 3, phase III, trial
BMS says Phase III trials for Opdivo show improved overall survival in lung cancer
May 19, 2016 Research and Development Bristol-Myers Squibb, drug trial, lung cancer, opdivo
FDA grants accelerated approval for Roche’s bladder cancer immunotherapy Tecentriq
May 19, 2016 Research and Development, Sales and Marketing FDA, Roche, atezolizumab, bladder cancer, immunotherapy, tecentriq
AstraZeneca’s Lynparza fails to meet primary endpoint in Phase III gastric cancer trials
May 18, 2016 Research and Development AstraZeneca, failed to meet endpoint, gastric trail, lynparza, phase III
Breast cancer trial stopped after meeting primary endpoint early
May 18, 2016 Research and Development LEE011, Novartis, breast cancer, progression free survival, ribociclib
Boehringer Ingelheim says new studies underline efficacy of lung disease drug
May 18, 2016 Research and Development, Sales and Marketing Boehringer Ingelheim, lung disease
Novartis splits pharmaceuticals division into two business units
May 18, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Novartis, epstein, new division
Opdivo nabs FDA approval in specific patients with Hodgkin lymphoma
May 18, 2016 Research and Development, Sales and Marketing Bristol-Myers Squibb, Hodgkin lymphoma, opdivo
Relmada Therapeutics appoints new chief financial officer
May 17, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing chief financial officer, relmada
Biogen signs $2 billion partnership deal with UPenn for gene therapies
May 17, 2016 Research and Development, Sales and Marketing Biogen, collaboration, deal, gene therapy, research
